29 results on '"Stone EM"'
Search Results
2. Exome-based investigation of the genetic basis of human pigmentary glaucoma.
- Author
-
van der Heide C, Goar W, Meyer KJ, Alward WLM, Boese EA, Sears NC, Roos BR, Kwon YH, DeLuca AP, Siggs OM, Gonzaga-Jauregui C, Sheffield VC, Wang K, Stone EM, Mullins RF, Anderson MG, Fan BJ, Ritch R, Craig JE, Wiggs JL, Scheetz TE, and Fingert JH
- Subjects
- Animals, Humans, Iris, Membrane Glycoproteins, Mice, Pigmentation, Exome Sequencing, Exome, Glaucoma, Open-Angle genetics
- Abstract
Background: Glaucoma is a leading cause of visual disability and blindness. Release of iris pigment within the eye, pigment dispersion syndrome (PDS), can lead to one type of glaucoma known as pigmentary glaucoma. PDS has a genetic component, however, the genes involved with this condition are largely unknown. We sought to discover genes that cause PDS by testing cohorts of patients and controls for mutations using a tiered analysis of exome data., Results: Our primary analysis evaluated melanosome-related genes that cause dispersion of iris pigment in mice (TYRP1, GPNMB, LYST, DCT, and MITF). We identified rare mutations, but they were not statistically enriched in PDS patients. Our secondary analyses examined PMEL (previously linked with PDS), MRAP, and 19 other genes. Four MRAP mutations were identified in PDS cases but not in controls (p = 0.016). Immunohistochemical analysis of human donor eyes revealed abundant MRAP protein in the iris, the source of pigment in PDS. However, analysis of MRAP in additional cohorts (415 cases and 1645 controls) did not support an association with PDS. We also did not confirm a link between PMEL and PDS in our cohorts due to lack of reported mutations and similar frequency of the variants in PDS patients as in control subjects., Conclusions: We did not detect a statistical enrichment of mutations in melanosome-related genes in human PDS patients and we found conflicting data about the likely pathogenicity of MRAP mutations. PDS may have a complex genetic basis that is not easily unraveled with exome analyses.
- Published
- 2021
- Full Text
- View/download PDF
3. Histochemical Analysis of Glaucoma Caused by a Myocilin Mutation in a Human Donor Eye.
- Author
-
van der Heide CJ, Alward WLM, Flamme-Wiese M, Riker M, Syed NA, Anderson MG, Carter K, Kuehn MH, Stone EM, Mullins RF, and Fingert JH
- Subjects
- Cytoskeletal Proteins metabolism, Endoplasmic Reticulum Chaperone BiP, Eye Proteins metabolism, Female, Glaucoma, Open-Angle metabolism, Glaucoma, Open-Angle physiopathology, Glycoproteins metabolism, Humans, Male, Middle Aged, Retrospective Studies, Aqueous Humor metabolism, Cytoskeletal Proteins genetics, DNA genetics, Eye Proteins genetics, Glaucoma, Open-Angle genetics, Glycoproteins genetics, Immunohistochemistry methods, Intraocular Pressure physiology, Mutation, Tissue Donors, Trabecular Meshwork metabolism
- Abstract
Objective: Mutations in myocilin ( MYOC) may cause either juvenile open angle glaucoma (JOAG) or adult-onset primary open angle glaucoma (POAG). MYOC encodes a glycoprotein that is normally secreted from trabecular meshwork cells that regulate intraocular pressure. Prior in vitro, transgenic rodent, and organ culture experiments have suggested that abnormal accumulation of MYOC protein within trabecular meshwork cells is a key step in glaucoma pathophysiology. We investigated the pathogenesis of MYOC glaucoma by examining a donor eye from a patient with JOAG caused by a Tyr437His MYOC mutation., Design: Case-control, immunohistochemical study of a donor eye from a patient with JOAG caused by a Tyr437His MYOC mutation and age-matched control donor eyes., Subjects: An eye from a 59-year-old male with JOAG caused by a Tyr437His MYOC mutation and eyes from five donors (ages 51-66) with no known ocular disease were examined., Methods: Frozen fixed sections of the iridocorneal angle were prepared from the donor eyes of the MYOC glaucoma patient and control eyes. We used antibodies directed against MYOC, collagen IV, and BiP/GRP78 as well as wheat germ agglutinin and concanavalin A lectins to localize MYOC protein in the trabecular meshwork., Main Outcome Measure: Qualitative comparison of MYOC protein labeling and localization in the trabecular meshwork of donor eyes from a glaucoma patient with a MYOC mutation and from control subjects., Results: Using immunohistochemistry, we detected more abundant MYOC protein within the trabecular meshwork of the MYOC glaucoma patient's eye than in control eyes. We further localized MYOC protein within the trabecular meshwork cells of the MYOC glaucoma patient's eye by co-labeling with the endoplasmic reticulum (ER) marker GRP78 (BiP). Little to no MYOC was identified within the trabecular meshwork cells of control eyes. Minimal extracellular MYOC was detected in both MYOC glaucoma eyes and control eyes., Conclusions: This is the first histopathological analysis of an eye from a glaucoma patient with a MYOC mutation. Furthermore, this analysis supports our model of MYOC-associated glaucoma, in which MYOC mutations cause abnormal intracellular retention of MYOC within the ER of trabecular meshwork cells as a key step towards development of glaucoma.
- Published
- 2018
- Full Text
- View/download PDF
4. A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel Loci.
- Author
-
Scheetz TE, Fingert JH, Wang K, Kuehn MH, Knudtson KL, Alward WL, Boldt HC, Russell SR, Folk JC, Casavant TL, Braun TA, Clark AF, Stone EM, and Sheffield VC
- Subjects
- Aged, Alleles, Amino Acid Sequence, Complement C7 chemistry, Complement C7 genetics, Cornea pathology, Female, Genetic Predisposition to Disease, Genotype, Glaucoma, Open-Angle pathology, Humans, Macular Degeneration pathology, Male, Middle Aged, Molecular Sequence Data, Polymorphism, Single Nucleotide, Quantitative Trait, Heritable, Sequence Alignment, Genome-Wide Association Study, Glaucoma, Open-Angle genetics, Macular Degeneration genetics, Quantitative Trait Loci
- Abstract
Glaucoma and age-related macular degeneration (AMD) are the two leading causes of visual loss in the United States. We utilized a novel study design to perform a genome-wide association for both primary open angle glaucoma (POAG) and AMD. This study design utilized a two-stage process for hypothesis generation and validation, in which each disease cohort was utilized as a control for the other. A total of 400 POAG patients and 400 AMD patients were ascertained and genotyped at 500,000 loci. This study identified a novel association of complement component 7 (C7) to POAG. Additionally, an association of central corneal thickness, a known risk factor for POAG, was found to be associated with ribophorin II (RPN2). Linked monogenic loci for POAG and AMD were also evaluated for evidence of association, none of which were found to be significantly associated. However, several yielded putative associations requiring validation. Our data suggest that POAG is more genetically complex than AMD, with no common risk alleles of large effect.
- Published
- 2013
- Full Text
- View/download PDF
5. Analysis of ASB10 variants in open angle glaucoma.
- Author
-
Fingert JH, Roos BR, Solivan-Timpe F, Miller KA, Oetting TA, Wang K, Kwon YH, Scheetz TE, Stone EM, and Alward WL
- Subjects
- Cohort Studies, Germany, Humans, Intraocular Pressure genetics, Iowa, Male, Middle Aged, Mutation, Oregon, Glaucoma, Open-Angle genetics, Suppressor of Cytokine Signaling Proteins genetics
- Abstract
Glaucoma is a common cause of visual disability and affects ∼1.6% of individuals over 40 years of age ( 1). Non-synonymous coding sequence variations in the ankyrin repeat and SOCS box containing gene 10 (ASB10) were recently associated with 6.0% of cases of primary open angle glaucoma (POAG) in patients from Oregon and Germany. We tested a cohort of POAG patients (n= 158) and normal control subjects (n= 82), both from Iowa, for ASB10 mutations. Our study had 80% power to detect a 4.9% mutation frequency in POAG patients. A total of 11 non-synonymous coding sequence mutations were detected in the cohort, but no association with POAG was detected when analyzed individually or as a group (P > 0.05). Furthermore, a survey of the National Heart, Lung, and Blood Institute's (NHLBI's) Exome Sequencing Project revealed that non-synonymous ASB10 mutations are present in the general population at a far higher frequency than the prevalence of POAG. These data suggest that non-synonymous mutations in ASB10 do not cause Mendelian forms of POAG.
- Published
- 2012
- Full Text
- View/download PDF
6. Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma.
- Author
-
Zode GS, Bugge KE, Mohan K, Grozdanic SD, Peters JC, Koehn DR, Anderson MG, Kardon RH, Stone EM, and Sheffield VC
- Subjects
- Administration, Ophthalmic, Animals, Anti-Bacterial Agents pharmacology, Aqueous Humor metabolism, Cytoskeletal Proteins metabolism, Disease Models, Animal, Eye drug effects, Eye Proteins metabolism, Female, Glaucoma, Open-Angle metabolism, Glycoproteins metabolism, Humans, Immunohistochemistry, Intraocular Pressure drug effects, Male, Mice, Mice, Transgenic, Ocular Hypertension drug therapy, Tunicamycin pharmacology, Glaucoma, Open-Angle drug therapy, Ophthalmic Solutions administration & dosage, Phenylbutyrates administration & dosage
- Abstract
Purpose: Mutations in the myocilin gene (MYOC) are the most common known genetic cause of primary open-angle glaucoma (POAG). The purpose of this study was to determine whether topical ocular sodium 4-phenylbutyrate (PBA) treatment rescues glaucoma phenotypes in a mouse model of myocilin-associated glaucoma (Tg-MYOC(Y437H) mice)., Methods: Tg-MYOC(Y437H) mice were treated with PBA eye drops (n = 10) or sterile PBS (n = 8) twice daily for 5 months. Long-term safety and effectiveness of topical PBA (0.2%) on glaucoma phenotypes were examined by measuring intraocular pressure (IOP) and pattern ERG (PERG), performing slit lamp evaluation of the anterior chamber, analyzing histologic sections of the anterior segment, and comparing myocilin levels in the aqueous humor and trabecular meshwork of Tg-MYOC(Y437H) mice., Results: Tg-MYOC(Y437H) mice developed elevated IOP at 3 months of age when compared with wild-type (WT) littermates (n = 24; P < 0.0001). Topical PBA did not alter IOP in WT mice. However, it significantly reduced elevated IOP in Tg-MYOC(Y437H) mice to the level of WT mice. Topical PBA-treated Tg-MYOC(Y437H) mice also preserved PERG amplitudes compared with vehicle-treated Tg-MYOC(Y437H) mice. No structural abnormalities were observed in the anterior chamber of PBA-treated WT and Tg-MYOC(Y437H) mice. Analysis of the myocilin in the aqueous humor and TM revealed that PBA significantly improved the secretion of myocilin and reduced myocilin accumulation as well as endoplasmic reticulum (ER) stress in the TM of Tg-MYOC(Y437H) mice. Furthermore, topical PBA reduced IOP elevated by induction of ER stress via tunicamycin injections in WT mice., Conclusions: Topical ocular PBA reduces glaucomatous phenotypes in Tg-MYOC(Y437H) mice, most likely by reducing myocilin accumulation and ER stress in the TM. Topical ocular PBA could become a novel treatment for POAG patients with myocilin mutations.
- Published
- 2012
- Full Text
- View/download PDF
7. Localization of SH3PXD2B in human eyes and detection of rare variants in patients with anterior segment diseases and glaucoma.
- Author
-
Mao M, Solivan-Timpe F, Roos BR, Mullins RF, Oetting TA, Kwon YH, Brzeskiewicz PM, Stone EM, Alward WL, Anderson MG, and Fingert JH
- Subjects
- Adaptor Proteins, Signal Transducing metabolism, Animals, Anterior Eye Segment abnormalities, Anterior Eye Segment metabolism, Autopsy, Case-Control Studies, Exons, Eye Abnormalities pathology, Eye Diseases, Hereditary, Glaucoma congenital, Glaucoma pathology, Glaucoma, Open-Angle pathology, Humans, Immunohistochemistry, Male, Mice, Sequence Analysis, DNA, United States, Adaptor Proteins, Signal Transducing genetics, Anterior Eye Segment pathology, Eye Abnormalities genetics, Glaucoma genetics, Glaucoma, Open-Angle genetics, Polymorphism, Genetic
- Abstract
Purpose: Analysis of mutant mouse strains and linkage analysis with human families have both demonstrated that mutations influencing the podosomal adaptor protein SH3 and PX domains 2B (SH3PXD2B) can result in a congenital form of glaucoma. Here, we use immunohistochemistry to describe localization of the SH3PXD2B protein throughout the adult human eye and test whether sequence variants in SH3PXD2B occur in multiple other forms of glaucoma., Methods: In immunohistochemical experiments, cryosections of human donor eyes were evaluated for SH3PXD2B immunoreactivity with a polyclonal antibody. In genetic experiments, exon sequences of SH3PXD2B from patients with primary congenital glaucoma (n=21), Axenfeld-Rieger syndrome (n=30), and primary open angle glaucoma (n=127) were compared to control subjects (n=89). The frequency of non-synonymous SH3PXD2B coding sequence variants were compared between patient cohorts and controls using Fisher's exact test., Results: Varying intensities of SH3PXD2B immunoreactivity were detected in almost all ocular tissues. Among tissues important to glaucoma, immunoreactivity was detected in the drainage structures of the iridocorneal angle, ciliary body, and retinal ganglion cells. Intense immunoreactivity was present in photoreceptor inner segments. From DNA analysis, a total of 11 non-synonymous variants were detected. By Fisher's Exact test, there was not a significant skew in the overall frequency of these changes in any patient cohort versus controls (p-value >0.05). Each cohort contained unique variants not detected in other cohorts or patients., Conclusions: SH3PXD2B is widely distributed in the adult human eye, including several tissues important to glaucoma pathogenesis. Analysis of DNA variants in three forms of glaucoma detected multiple variants unique to each patient cohort. While statistical analysis failed to support a pathogenic role for these variants, some of them may be rare disease-causing variants whose biologic significance warrants investigation in follow up replication studies and functional assays.
- Published
- 2012
8. Copy number variations and primary open-angle glaucoma.
- Author
-
Davis LK, Meyer KJ, Schindler EI, Beck JS, Rudd DS, Grundstad AJ, Scheetz TE, Braun TA, Fingert JH, Alward WL, Kwon YH, Folk JC, Russell SR, Wassink TH, Sheffield VC, and Stone EM
- Subjects
- Comparative Genomic Hybridization, Female, Genome, Human genetics, Glaucoma, Open-Angle diagnosis, Humans, Male, Middle Aged, Oligonucleotide Array Sequence Analysis, Polymorphism, Single Nucleotide genetics, Reverse Transcriptase Polymerase Chain Reaction, DNA Copy Number Variations genetics, Genome-Wide Association Study, Glaucoma, Open-Angle genetics
- Abstract
Purpose: This study sought to investigate the role of rare copy number variation (CNV) in age-related disorders of blindness, with a focus on primary open-angle glaucoma (POAG). Data are reported from a whole-genome copy number screen in a large cohort of 400 individuals with POAG and 500 age-matched glaucoma-free subjects., Methods: DNA samples from patients and controls were tested for CNVs using a combination of two microarray platforms. The signal intensity data generated from these arrays were then analyzed with multiple CNV detection programs including CNAG version 2.0, PennCNV, and dChip., Results: A total of 11 validated CNVs were identified as recurrent in the POAG set and absent in the age-matched control set. This set included CNVs on 5q23.1 (DMXL1, DTWD2), 20p12 (PAK7), 12q14 (C12orf56, XPOT, TBK1, and RASSF3), 12p13.33 (TULP3), and 10q34.21 (PAX2), among others. The CNVs presented here are exceedingly rare and are not found in the Database of Genomic Variants. Moreover, expression data from ocular tissue support the role of these CNV-implicated genes in vision-related processes. In addition, CNV locations of DMXL1 and PAK7 overlap previously identified linkage signals for glaucoma on 5p23.1 and 20p12, respectively., Conclusions: The data are consistent with the hypothesis that rare CNV plays a role in the development of POAG.
- Published
- 2011
- Full Text
- View/download PDF
9. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma.
- Author
-
Zode GS, Kuehn MH, Nishimura DY, Searby CC, Mohan K, Grozdanic SD, Bugge K, Anderson MG, Clark AF, Stone EM, and Sheffield VC
- Subjects
- Animals, Apoptosis physiology, Cells, Cultured, Cytoskeletal Proteins genetics, Endoplasmic Reticulum pathology, Eye Proteins genetics, Glaucoma, Open-Angle genetics, Glaucoma, Open-Angle pathology, Glycoproteins genetics, Humans, Intraocular Pressure, Mice, Mice, Transgenic, Mutation, Phenotype, Trabecular Meshwork cytology, Trabecular Meshwork metabolism, Trabecular Meshwork pathology, Transgenes, Unfolded Protein Response, Endoplasmic Reticulum drug effects, Endoplasmic Reticulum metabolism, Glaucoma, Open-Angle drug therapy, Glaucoma, Open-Angle physiopathology, Phenylbutyrates pharmacology, Phenylbutyrates therapeutic use, Stress, Physiological
- Abstract
Mutations in myocilin (MYOC) are the most common genetic cause of primary open angle glaucoma (POAG), but the mechanisms underlying MYOC-associated glaucoma are not fully understood. Here, we report the development of a transgenic mouse model of POAG caused by the Y437H MYOC mutation; the mice are referred to herein as Tg-MYOC(Y437H) mice. Analysis of adult Tg-MYOC(Y437H) mice, which we showed express human MYOC containing the Y437H mutation within relevant eye tissues, revealed that they display glaucoma phenotypes (i.e., elevated intraocular pressure [IOP], retinal ganglion cell death, and axonal degeneration) closely resembling those seen in patients with POAG caused by the Y437H MYOC mutation. Mutant myocilin was not secreted into the aqueous humor but accumulated in the ER of the trabecular meshwork (TM), thereby inducing ER stress in the TM of Tg-MYOC(Y437H) mice. Furthermore, chronic and persistent ER stress was found to be associated with TM cell death and elevation of IOP in Tg-MYOC(Y437H) mice. Reduction of ER stress with a chemical chaperone, phenylbutyric acid (PBA), prevented glaucoma phenotypes in Tg-MYOC(Y437H) mice by promoting the secretion of mutant myocilin in the aqueous humor and by decreasing intracellular accumulation of myocilin in the ER, thus preventing TM cell death. These results demonstrate that ER stress is linked to the pathogenesis of POAG and may be a target for treatment in human patients.
- Published
- 2011
- Full Text
- View/download PDF
10. Chromosome 7q31 POAG locus: ocular expression of caveolins and lack of association with POAG in a US cohort.
- Author
-
Kuehn MH, Wang K, Roos B, Stone EM, Kwon YH, Alward WL, Mullins RF, and Fingert JH
- Subjects
- Alleles, Cohort Studies, Gene Frequency, Genotype, Glaucoma, Open-Angle genetics, Humans, Immunohistochemistry methods, Models, Statistical, Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Risk Factors, United States, Caveolin 1 biosynthesis, Caveolin 1 genetics, Caveolin 2 biosynthesis, Caveolin 2 genetics, Chromosomes, Human, Pair 7, Glaucoma, Open-Angle diagnosis
- Abstract
Purpose: To determine the role of the recently discovered primary open angle glaucoma (POAG) risk factor mapped to chromosome 7q31 in glaucoma patients from Iowa and to determine the expression pattern of genes in the locus in human eyes., Methods: A cohort of 545 POAG patients and 297 control subjects from Iowa were genotyped with a single nucleotide polymorphism (SNP; rs4236601) in the chromosome 7q31 locus using a quantitative polymerase chain reaction (PCR) assay. The expression of genes within the 7q31 locus, caveolin-1 (CAV1) and caveolin-2 (CAV2) in human eyes was investigated with immunohistochemistry., Results: The minor allele frequency (MAF) of rs4236601 was 27% in control subjects and 29% in POAG patients. We detected no statistical difference when we compared the allele frequencies of rs4236601 between POAG patients and control subjects (p=0.5). Similarly, we detected no statistical difference in the frequency of the three possible rs4236601 genotypes between patients and controls (p=0.22). Immunohistochemistry showed caveolin expression in human retina, ciliary muscle, trabecular meshwork, and Schlemm's canal. In our small cohort of donor eyes, the genotype of rs4236601 did not obviously influence labeling intensity or distribution of CAV1 and CAV2 in the retina., Conclusions: A genome-wide association study of subjects from Iceland mapped the first common genetic risk factor for POAG to a small region of the genome on chromosome 7q31 that contains the caveolin genes CAV1 and CAV2. We were unable to detect this association in our patients from Iowa, suggesting that this risk factor may not have a strong effect in all populations.
- Published
- 2011
11. Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure.
- Author
-
Shepard AR, Jacobson N, Millar JC, Pang IH, Steely HT, Searby CC, Sheffield VC, Stone EM, and Clark AF
- Subjects
- Animals, COS Cells, Cell Line, Chlorocebus aethiops, Cytoskeletal Proteins genetics, Eye physiopathology, Eye Proteins genetics, Glaucoma, Open-Angle metabolism, Glaucoma, Open-Angle physiopathology, Glycoproteins genetics, Humans, Mice, Peroxisome-Targeting Signal 1 Receptor, Cytoskeletal Proteins metabolism, Eye Proteins metabolism, Glaucoma, Open-Angle genetics, Glycoproteins metabolism, Intraocular Pressure, Peroxisomes metabolism, Receptors, Cytoplasmic and Nuclear metabolism
- Abstract
Glaucoma is a leading cause of worldwide irreversible visual impairment and blindness and is a clinically and genetically heterogenous group of optic neuropathies. Specific mutations in the myocilin (MYOC) gene cause primary open angle glaucoma (POAG) with varying age-of-onset and degree of severity. We show a mutation-dependent, gain-of-function association between human myocilin and the peroxisomal targeting signal type 1 receptor (PTS1R). There was correlation between the glaucoma phenotype and the specific MYOC mutations, with the more severe early-onset POAG mutations having a higher degree of association with PTS1R. Expression of human myocilin glaucomatous mutations in mouse eyes causes elevated intraocular pressure, which is a major phenotype of MYOC glaucoma. This is the first demonstration of a disease resulting from mutation-induced exposure of a cryptic signaling site that causes mislocalization of mutant protein to peroxisomes and the first disease-gene-based animal model of human POAG.
- Published
- 2007
- Full Text
- View/download PDF
12. No association between variations in the WDR36 gene and primary open-angle glaucoma.
- Author
-
Fingert JH, Alward WL, Kwon YH, Shankar SP, Andorf JL, Mackey DA, Sheffield VC, and Stone EM
- Subjects
- Humans, Polymorphism, Single-Stranded Conformational, Eye Proteins genetics, Genetic Variation, Glaucoma, Open-Angle genetics
- Published
- 2007
- Full Text
- View/download PDF
13. The optic nerve head in myocilin glaucoma.
- Author
-
Hewitt AW, Bennett SL, Fingert JH, Cooper RL, Stone EM, Craig JE, and Mackey DA
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Case-Control Studies, DNA Mutational Analysis, Female, Humans, Intraocular Pressure, Male, Middle Aged, Optic Nerve Diseases genetics, Polymerase Chain Reaction, Polymorphism, Single-Stranded Conformational, Cytoskeletal Proteins genetics, Eye Proteins genetics, Glaucoma, Open-Angle diagnosis, Glaucoma, Open-Angle genetics, Glycoproteins genetics, Mutation, Optic Disk pathology, Optic Nerve Diseases diagnosis
- Abstract
Purpose: Approximately 1 in 30 unselected patients with open-angle glaucoma (OAG) have a mutation in the myocilin gene. The purpose of this study was to describe the morphologic features of the optic nerve head (ONH) in myocilin glaucoma., Methods: A case-control design was adopted. Sixty-six patients heterozygous for a range of myocilin mutation (cases) were matched in disease severity to 105 patients with OAG known not to have a myocilin mutation (controls), using visual field findings. Quantifiable analysis of the ONH was undertaken of stereoscopic photographs, by using custom software with a z-screen. Subjective grading of the cup depth, lamina cribrosa pore shape and orientation, and the slope of the neuroretinal rim was performed by an examiner masked to the subject's mutation status. Mutation screening was conducted using either direct sequencing or single-stranded conformation polymorphism analysis., Results: Patients with a myocilin mutation had glaucoma diagnosed earlier (P < 0.001) and had higher maximum recorded intraocular pressures (P < 0.001) than did the control OAG subjects. There was no significant (P > 0.05) difference in global disc area, global neuroretinal rim area, alpha-parapapillary atrophy, beta-parapapillary atrophy, slope of neuroretinal rim, or visible lamina cribrosa morphology between myocilin mutation carriers and patients with nonmyocilin glaucoma. Disc hemorrhages were identified more frequently in those without mutations (14/209 vs. 1/129), though this was not significant after correction for multiple hypothesis testing., Conclusions: No major structural or morphologic difference of the ONH was detected in pooled data from subjects who had myocilin mutations compared with data from individuals with nonmyocilin glaucoma.
- Published
- 2007
- Full Text
- View/download PDF
14. The C677T variant in the methylenetetrahydrofolate reductase gene is not associated with disease in cohorts of pseudoexfoliation glaucoma and primary open-angle glaucoma patients from Iowa.
- Author
-
Fingert JH, Kwon YH, Moore PA, Johnston RM, Kim KY, Sheffield VC, Alward WL, and Stone EM
- Subjects
- Adult, Gene Amplification, Gene Frequency, Genotype, Humans, Intraocular Pressure, Iowa, Polymerase Chain Reaction, Exfoliation Syndrome genetics, Genetic Variation, Glaucoma, Open-Angle genetics, Hyperhomocysteinemia genetics, Methylenetetrahydrofolate Reductase (NADPH2) genetics
- Published
- 2006
- Full Text
- View/download PDF
15. Attitudes to predictive DNA testing for myocilin glaucoma: experience with a large Australian family.
- Author
-
Healey DL, Craig JE, Wilkinson CH, Stone EM, and Mackey DA
- Subjects
- Australia, Cytoskeletal Proteins, DNA Mutational Analysis psychology, Genetic Counseling, Genetic Predisposition to Disease genetics, Glaucoma, Open-Angle genetics, Humans, Pedigree, Attitude to Health, DNA genetics, Eye Proteins genetics, Genetic Predisposition to Disease psychology, Genetic Testing psychology, Glaucoma, Open-Angle psychology, Glycoproteins genetics
- Abstract
Purpose: Glaucoma is a major cause of visual impairment and blindness in developed countries. Half of those with glaucoma are unaware that they have the disease. Mutations in the myocilin (MYOC) gene are responsible for 3 to 5% of primary open angle glaucoma, thus predictive DNA testing in family members of some glaucoma pedigrees is possible. We wished to determine the attitudes of affected and unaffected family members to the use of predictive DNA testing in glaucoma., Subjects and Methods: We surveyed the attitudes of family members from one such pedigree to determine the acceptability of predictive DNA testing. We studied 72 members of a large family in which the MYOC mutation, THR377MET, segregates. Family members were examined over an 8-year period as part of research initiated to identify the gene. Once the mutation was identified, we offered participants the result of their DNA test after a genetic counseling session. Family members were subsequently given a questionnaire about the counseling and DNA result., Results: Most wished to know their result after counseling; 26 of 27 (96%) felt the genetic counseling session was necessary, but participants' attitudes varied as to whether they preferred this in person, by phone, or letter. Forty three patients were resurveyed 5 years after their initial counseling session. No adverse problems relating to the predictive testing were reported, though two had been asked about DNA testing by insurance companies; 5 of 24 (21%) individuals who had been informed they did not carry the mutation were unsure if they carried the mutation 5 years after counseling, while all 19 mutation carriers (who were being examined annually) correctly recalled their mutation status., Conclusions: This study suggests that predictive glaucoma testing in appropriate circumstances is acceptable to patients and their families.
- Published
- 2004
- Full Text
- View/download PDF
16. Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma.
- Author
-
Alward WL, Kwon YH, Kawase K, Craig JE, Hayreh SS, Johnson AT, Khanna CL, Yamamoto T, Mackey DA, Roos BR, Affatigato LM, Sheffield VC, and Stone EM
- Subjects
- Base Sequence, Case-Control Studies, Cell Cycle Proteins, DNA Primers chemistry, Female, Humans, Membrane Transport Proteins, Middle Aged, Polymerase Chain Reaction, Polymorphism, Single-Stranded Conformational, Prospective Studies, Sequence Analysis, DNA, Eye Proteins genetics, Glaucoma, Open-Angle genetics, Nerve Tissue Proteins genetics, Transcription Factor TFIIIA
- Abstract
Purpose: To investigate the association of sequence variations in the optineurin (OPTN) gene in patients with open-angle glaucoma., Design: Prospective case control study., Methods: The OPTN gene was screened for sequence variations using a combination of single-strand conformational polymorphism analysis and automated DNA sequencing. A total of 1,299 subjects (1048 glaucoma patients and 251 controls) were screened for variations in the four portions of the gene that had been previously associated with glaucoma. A subset of these subjects (376 patients and 176 controls) was screened for variations in the entire coding sequence. Twenty-four percent of the patients and 35% of the controls were Japanese, whereas the remainder were predominantly Caucasian. Allele frequencies were compared with the Fisher exact test., Results: The OPTN sequence variations were not significantly associated with any form of high-tension open-angle glaucoma. One proband with familial normal-tension glaucoma was found to harbor the previously reported Glu50Lys variation. Another previously reported change, Met98Lys, was associated with normal-tension glaucoma in Japanese but not in Caucasian patients., Conclusions: This study provides some additional evidence for the association of the Glu50Lys OPTN sequence variation with familial normal tension glaucoma. However, because familial normal-tension glaucoma is so rare, this change seems to be responsible for less than 0.1% of all open-angle glaucoma. The Arg545Gln variation is likely to be a nondisease-causing polymorphism. The Met98Lys change may be associated with a fraction of normal-tension glaucoma in patients of Japanese ethnicity.
- Published
- 2003
- Full Text
- View/download PDF
17. Glaucoma phenotype in pedigrees with the myocilin Thr377Met mutation.
- Author
-
Mackey DA, Healey DL, Fingert JH, Coote MA, Wong TL, Wilkinson CH, McCartney PJ, Rait JL, de Graaf AP, Stone EM, and Craig JE
- Subjects
- Adult, Aged, Australia, Cross-Sectional Studies, Cytoskeletal Proteins, DNA Mutational Analysis, Female, Genetic Linkage, Haplotypes, Humans, Intraocular Pressure, Male, Middle Aged, Ocular Hypertension genetics, Ocular Hypertension pathology, Optic Disk pathology, Pedigree, Phenotype, Polymorphism, Single-Stranded Conformational, Visual Fields, Eye Proteins genetics, Glaucoma, Open-Angle genetics, Glaucoma, Open-Angle pathology, Glycoproteins genetics, Mutation, Missense
- Abstract
Objective: To investigate the phenotype and age-related penetrance of primary open-angle glaucoma (POAG) in Australian families with the myocilin mutation Thr377Met., Method and Design: Cross-sectional genetic study. Four unrelated pedigrees carrying the Thr377Met mutation were ascertained from more than 2000 consecutive cases of POAG in the Glaucoma Inheritance Study in Tasmania and from families with glaucoma referred to the study from throughout Australia. Index cases and available family members were examined for signs of glaucoma, and the presence of the GLC1A Thr377Met mutation was ascertained by single-strand conformation polymorphism analysis and subsequent direct sequencing., Results: From the 4 pedigrees carrying the Thr377Met mutation, 23 individuals with either ocular hypertension (OHT) or POAG were found, with a mean +/- SD age at diagnosis of 41.2 +/- 11.5 years, and a mean peak intraocular pressure of 31.7 +/- 9.9 mm Hg. A further 9 mutation carriers older than 18 years were studied who as yet showed no signs of OHT or POAG (6 of these 9 were younger than 30 years). A single individual with POAG was identified who did not carry the Thr377Met mutation. For Thr377Met carriers, age-related penetrance for OHT or POAG was 88% at age 30 years. A positive family history of POAG was present for 3 of the 4 index cases. Thirteen (57%) of the 23 Thr377Met carriers with OHT or POAG had undergone glaucoma drainage surgery. Although the glaucoma in these families appears to be pressure dependent, 2 individuals showed optic disc cupping before detected elevation in intraocular pressure. One family was of British origin, with a different background haplotype from the other 3 families from Greece or Macedonia, who shared a common haplotype., Conclusions: The GLC1A Thr377Met mutation is associated with POAG that, in the pedigrees studied, had a younger age at onset and higher peak intraocular pressure than in pedigrees with the more common Gln368STOP mutation. In addition, patients with glaucoma with the Thr377Met mutation were more likely to have undergone glaucoma drainage surgery.
- Published
- 2003
- Full Text
- View/download PDF
18. A case-control comparison of the clinical characteristics of glaucoma and ocular hypertensive patients with and without the myocilin Gln368Stop mutation.
- Author
-
Graul TA, Kwon YH, Zimmerman MB, Kim CS, Sheffield VC, Stone EM, and Alward WL
- Subjects
- Adult, Age of Onset, Aged, Aged, 80 and over, Case-Control Studies, Cytoskeletal Proteins, Female, Humans, Intraocular Pressure, Male, Middle Aged, Ocular Hypertension genetics, Ocular Hypertension pathology, Retrospective Studies, Visual Acuity, Visual Fields, Codon, Terminator genetics, Eye Proteins genetics, Glaucoma, Open-Angle genetics, Glaucoma, Open-Angle pathology, Glycoproteins genetics, Mutation
- Abstract
Purpose: To determine whether primary open-angle glaucoma (POAG) and ocular hypertensive (OHT) patients who harbor the myocilin Gln368Stop mutation differ in phenotype or clinical course from patients without the mutation., Design: Case-control study., Methods: A retrospective case-control study compared all known POAG patients (n = 18) and OHT patients (n = 4) harboring the Gln368Stop mutation evaluated by the University of Iowa Glaucoma Service with control patients from the same population. Patients and control subjects were matched for diagnosis, age, sex, and race and were compared for phenotype and clinical course., Results: Mean age of disease onset and mean peak intraocular pressures (IOPs) of cases were similar to those reported by other studies. There was no statistically significant difference between cases and controls for the following variables: age at onset, peak intraocular pressure, Snellen visual acuity, number of medications, Humphrey visual field (HVF) mean deviation, HVF pattern deviation, number of filtering surgeries performed, time intervals from diagnosis to argon laser trabeculoplasty (ALT), diagnosis to first filtering surgery, ALT to first filtering surgery, and percent change in IOP after ALT and after first filtering surgery., Conclusions: There is no statistically significant difference between the onset and clinical course of POAG and OHT caused by the Gln368Stop mutation and POAG and OHT not associated with the mutation.
- Published
- 2002
- Full Text
- View/download PDF
19. Myocilin glaucoma.
- Author
-
Fingert JH, Stone EM, Sheffield VC, and Alward WL
- Subjects
- Cytoskeletal Proteins, Genetic Linkage, Humans, Intraocular Pressure, Pedigree, Eye Proteins genetics, Glaucoma, Open-Angle genetics, Glycoproteins genetics, Mutation
- Abstract
Genetic factors have long been implicated in the pathophysiology of primary open-angle glaucoma (POAG). Recently, myocilin, a gene of unknown function, was associated with both juvenile open-angle glaucoma (JOAG) and POAG. Forty-three different myocilin mutations have been reported in open-angle glaucoma patients, and several large studies have suggested that as a group these mutations are associated with 3-4% of POAG in patient populations worldwide. Support for the pathogenicity of the individual myocilin mutations has been obtained from in vitro assays, statistical methods, and conservation of gene sequence arguments. Several of these myocilin mutations were observed in multiple patients allowing the identification of mutation-specific glaucoma phenotypes (maximum intraocular pressure and age at diagnosis). Associations between myocilin and other forms of open-angle glaucoma have been explored. At present there is no evidence to link myocilin mutations and steroid-induced ocular hypertension or normal-tension glaucoma. Clinical vignettes of POAG patients from four generations of a family harboring the TYR437HIS myocilin mutation are presented, highlighting the benefits of elucidating the genetics of glaucoma.
- Published
- 2002
- Full Text
- View/download PDF
20. Variations in the myocilin gene in patients with open-angle glaucoma.
- Author
-
Alward WL, Kwon YH, Khanna CL, Johnson AT, Hayreh SS, Zimmerman MB, Narkiewicz J, Andorf JL, Moore PA, Fingert JH, Sheffield VC, and Stone EM
- Subjects
- Adult, Aged, Aged, 80 and over, Cytoskeletal Proteins, Female, Humans, Male, Middle Aged, Phenotype, Polymorphism, Genetic, Prevalence, Sequence Analysis, DNA, Eye Proteins genetics, Genetic Variation genetics, Glaucoma, Open-Angle genetics, Glycoproteins genetics
- Abstract
Objective: To determine the prevalence and associated phenotype of myocilin (MYOC) coding sequence variations and a specific promoter polymorphism (MYOC.mt1) in patients with glaucoma and glaucoma suspects., Methods: A consecutive, unselected series of 779 patients (652 with open-angle glaucoma and 127 glaucoma suspects) were recruited from a university medical center and clinically characterized. The coding sequences of the MYOC gene and the MYOC.mt1 locus in the promoter region were screened for sequence variations. We determined the prevalence of MYOC coding sequence mutations and the MYOC.mt1 promoter polymorphism. We also compared the clinical features of individuals with and without mutations and the MYOC.mt1 promoter polymorphism., Results: Plausible disease-causing sequence variations (DCVs) in the MYOC gene were found in 3.0% of the entire group. Such variations were found in patients with most forms of open-angle glaucoma studied. Patients with primary open-angle glaucoma (POAG) who harbored coding sequence DCVs were clinically similar to patients without them. Patients who harbored the rarer allele of the MYOC.mt1 promoter polymorphism were no different in any measure of disease severity from those who harbored the more common allele., Conclusions: MYOC DCVs were found in approximately 3% of patients with glaucoma and glaucoma suspects. The 2 alleles of the MYOC.mt1 promoter polymorphism were equally distributed among patients with POAG and healthy control subjects. Patients with POAG who harbored the rarer allele of the MYOC.mt1 promoter polymorphism were no different from those with the more common variant in any measure of disease severity., Clinical Relevance: Testing for the MYOC.mt1 promoter polymorphism appears to be of no value in the evaluation of patients with glaucoma.
- Published
- 2002
- Full Text
- View/download PDF
21. Evidence for genetic heterogeneity within eight glaucoma families, with the GLC1A Gln368STOP mutation being an important phenotypic modifier.
- Author
-
Craig JE, Baird PN, Healey DL, McNaught AI, McCartney PJ, Rait JL, Dickinson JL, Roe L, Fingert JH, Stone EM, and Mackey DA
- Subjects
- Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Cytoskeletal Proteins, DNA Mutational Analysis, Effect Modifier, Epidemiologic, Female, Genetic Carrier Screening, Glaucoma, Open-Angle diagnosis, Glaucoma, Open-Angle epidemiology, Glutamine, Humans, Intraocular Pressure, Male, Middle Aged, Optic Disk pathology, Pedigree, Phenotype, Polymorphism, Single-Stranded Conformational, Tasmania epidemiology, Visual Fields, Codon, Nonsense, Eye Proteins genetics, Genetic Heterogeneity, Glaucoma, Open-Angle genetics, Glycoproteins genetics
- Abstract
Objective: To investigate the phenotype and age-related penetrance of primary open-angle glaucoma (POAG) in Australian families with the most common Myocilin mutation (Gln368STOP)., Design: Cross-sectional genetic study., Participants: Eight pedigrees carrying the Gln368STOP mutation were ascertained from 1730 consecutive cases of POAG in the Glaucoma Inheritance Study in Tasmania., Methods: Index cases and available family members were examined for signs of glaucoma, and the presence of the GLC1A Gln368STOP mutation was ascertained by single-strand conformation polymorphism analysis and subsequent direct sequencing., Results: From the eight pedigrees, 29 Gln368STOP mutation-carrying individuals with either ocular hypertension (OHT) or POAG were found, with a mean age at diagnosis of 52.4 +/- 12.9 years and a mean peak intraocular pressure (IOP) of 28.4 +/- 4.7 mmHg. A further 11 mutation carriers older than 40 years have been studied, who as yet show no signs of OHT or POAG. Within the 8 pedigrees, a further 31 individuals with OHT or POAG were identified who did not carry the Gln368STOP mutation. For these individuals the mean age at diagnosis was higher (62.3 +/- 13.7 years, P < 0.01), and the mean peak IOP was lower (25.4 +/- 6.4 mmHg, P = 0.01). For Gln368STOP carriers, age-related penetrance for OHT or POAG was 72% at age 40 years and 82% at age 65 years. A positive family history of POAG was present in all index cases. Five of the eight pedigrees had a positive family history on both maternal and paternal sides. Seven of the eight pedigrees had one or more individuals with POAG who did not carry the mutation. Eight of the 29 Gln368STOP carriers with OHT or POAG had undergone trabeculectomy., Conclusions: The GLC1A Gln368STOP mutation is associated with POAG, which in the pedigrees studied is of a younger age of onset and higher peak IOP than non-mutation glaucoma cases. In addition, Gln368STOP mutation glaucoma cases were more likely to have undergone glaucoma drainage surgery. We have not observed simple autosomal dominant inheritance patterns for POAG in these pedigrees. Other factors, as yet uncharacterized, are involved in expression of the POAG phenotype in Gln368STOP pedigrees.
- Published
- 2001
- Full Text
- View/download PDF
22. The genetic aspects of adult-onset glaucoma: a perspective from the Greater Toronto area.
- Author
-
Williams-Lyn D, Flanagan J, Buys Y, Trope GE, Fingert J, Stone EM, and Héon E
- Subjects
- Adult, Age of Onset, Cytoskeletal Proteins, DNA analysis, DNA Mutational Analysis, Eye Proteins metabolism, Genetic Markers, Genotype, Glaucoma, Open-Angle epidemiology, Glaucoma, Open-Angle metabolism, Glycoproteins metabolism, Humans, Middle Aged, Mutation, Ontario epidemiology, Phenotype, Polymorphism, Single-Stranded Conformational, Retrospective Studies, Eye Proteins genetics, Glaucoma, Open-Angle genetics, Glycoproteins genetics
- Abstract
Background: The myocilin gene is the first glaucoma gene to be associated with primary open-angle glaucoma (POAG). The hereditary subset of POAG and the role of the myocilin gene in our population are not clearly defined. Identification of cases of hereditary glaucoma and a better appreciation of the role of the myocilin gene may allow earlier diagnosis of the disease and optimize management of those at risk for glaucoma., Methods: Patients were recruited from university glaucoma practices in the Greater Toronto area from 1996 to 1998. Pedigree analysis and DNA banking were performed for each participant. Mutational analysis of the myocilin gene by means of single-strand conformation polymorphism analysis and direct sequencing was completed for 140 probands with POAG of diverse ethnic background., Results: A total of 103 patients (55.7%) had a family history of glaucoma. Disease-causing mutations of the myocilin gene were observed in 7 (5.0%) of the 140 probands, which accounted for 6.5% (5/77) of the familial cases. Most mutations were associated with familial disease, which implies a 50% risk of transmission of a high-risk factor for glaucoma., Interpretation: The hereditary subset of POAG is significant, and heritable glaucoma should always be suspected. In spite of the diversity of the ethnic background of our subjects, the observed prevalence of myocilin gene mutations was comparable to that previously reported, and such mutations do not appear to spare any ethnic group.
- Published
- 2000
- Full Text
- View/download PDF
23. Expression pattern and in situ localization of the mouse homologue of the human MYOC (GLC1A) gene in adult brain.
- Author
-
Swiderski RE, Ying L, Cassell MD, Alward WL, Stone EM, and Sheffield VC
- Subjects
- Animals, Cytoskeletal Proteins, Disease Models, Animal, Embryonic and Fetal Development physiology, Humans, In Situ Hybridization, Mice, Brain Chemistry physiology, Eye Proteins genetics, Gene Expression Regulation physiology, Glaucoma, Open-Angle genetics, Glycoproteins genetics, Nerve Tissue Proteins genetics
- Abstract
The MYOC (GLC1A) gene has recently been associated with both juvenile-onset primary open angle glaucoma (JOAG) and typical late-onset primary open angle glaucoma (POAG). As a result, much scrutiny has been focused on the pathology of these diseases. In order to better understand the pathophysiology of POAG, we have been developing a mouse model of the disease. As a step in this development, we have investigated the expression pattern of Myoc transcripts in embryonic and adult mouse tissue using Northern blot and in situ hybridization analyses. Myoc transcripts were found in high levels in adult eye, heart, brain, skeletal muscle and testis and to a lesser extent in lung and kidney. They were also present, albeit in very low amounts, during mouse embryogenesis. We present new evidence using in situ hybridization analysis that Myoc transcripts were present in widespread regions of the adult brain including the ependymal lining of the third and fourth ventricles, in the choroid plexus, the zonal layer of the junction of the inferior and superior colliculi, the neurons of the habenula, the piriform cortex, the median pre-optic nucleus of the hypothalamus, the olfactory tubercle, and in the inferior olive. In a functional sense, Myoc expression in the ependyma and choroid plexus, two regions of the brain involved in cerebrospinal fluid synthesis and resorption, parallels Myoc expression in the ciliary body and trabecular meshwork of the anterior segment of the eye where aqueous humor synthesis and outflow occur., (Copyright 1999 Elsevier Science B.V.)
- Published
- 1999
- Full Text
- View/download PDF
24. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A)
- Author
-
Alward WL, Fingert JH, Coote MA, Johnson AT, Lerner SF, Junqua D, Durcan FJ, McCartney PJ, Mackey DA, Sheffield VC, and Stone EM
- Subjects
- Age of Onset, Aged, Case-Control Studies, Cytoskeletal Proteins, Female, Humans, Lod Score, Male, Chromosomes, Human, Pair 1, Eye Proteins genetics, Glaucoma, Open-Angle genetics, Glycoproteins genetics, Mutation
- Abstract
Background: A substantial proportion of cases of glaucoma have a genetic basis. Mutations causing glaucoma have been identified in the chromosome 1 open-angle glaucoma gene (GLC1A), which encodes a 57-kd protein known as myocilin. The normal role of this protein and the mechanism by which mutations cause glaucoma are not known., Methods: We screened 716 patients with primary open-angle glaucoma and 596 control subjects for sequence changes in the GLC1A gene., Results: We identified 16 sequence variations that met the criteria for a probable disease-causing mutation because they altered the predicted amino acid sequence and they were found in one or more patients with glaucoma, in less than 1 percent of the control subjects. These 16 mutations were found in 33 patients (4.6 percent). Six of the mutations were found in more than 1 subject (total, 99). Clinical features associated with these six mutations included an age at diagnosis ranging from 8 to 77 years and maximal recorded intraocular pressures ranging from 12 to 77 mm Hg., Conclusions: A variety of mutations in the GLC1A gene are associated with glaucoma. The spectrum of disease can range from juvenile glaucoma to typical late-onset primary open-angle glaucoma.
- Published
- 1998
- Full Text
- View/download PDF
25. Characterization and comparison of the human and mouse GLC1A glaucoma genes.
- Author
-
Fingert JH, Ying L, Swiderski RE, Nystuen AM, Arbour NC, Alward WL, Sheffield VC, and Stone EM
- Subjects
- Amino Acid Sequence, Amino Acid Substitution genetics, Animals, Base Sequence, Conserved Sequence, Cytoskeletal Proteins, Exons, Eye Proteins analysis, Eye Proteins biosynthesis, Gene Expression, Glycoproteins analysis, Glycoproteins biosynthesis, Humans, Introns, Mice, Molecular Sequence Data, Organ Specificity genetics, Eye Proteins genetics, Glaucoma, Open-Angle genetics, Glycoproteins genetics
- Abstract
The GLC1A gene (which encodes the protein myocilin) has been associated with the development of primary open angle glaucoma. Bacterial artificial chromosomes containing the human GLC1A gene and its mouse ortholog were subcloned and sequenced to reveal the genomic structure of the genes. Comparison of the coding sequences of the human and mouse GLC1A genes revealed a high degree of amino acid homology (82%) and the presence of several conserved motifs in the predicted GLC1A proteins. The expression of GLC1A was examined by Northern blot analysis of RNA from adult human tissues. GLC1A expression was observed in 17 of 23 tissues tested, suggesting a wider range of expression than was recognized previously. The comparison of the human and mouse GLC1A genes suggests that the mouse may be a useful model organism in studying the molecular pathophysiology of glaucoma.
- Published
- 1998
- Full Text
- View/download PDF
26. Identification of a gene that causes primary open angle glaucoma.
- Author
-
Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, Mackey DA, Ritch R, Kalenak JW, Craven ER, and Sheffield VC
- Subjects
- Base Sequence, Chromosome Mapping, Chromosomes, Artificial, Yeast, Cytoskeletal Proteins, Female, Genetic Linkage, Haplotypes, Humans, Male, Molecular Sequence Data, Mutation, Pedigree, Polymerase Chain Reaction, Polymorphism, Single-Stranded Conformational, Sequence Tagged Sites, Chromosomes, Human, Pair 1, Eye Proteins genetics, Glaucoma, Open-Angle genetics, Glycoproteins, Trabecular Meshwork metabolism
- Abstract
Glaucoma is a major cause of blindness and is characterized by progressive degeneration of the optic nerve and is usually associated with elevated intraocular pressure. Analyses of sequence tagged site (STS) content and haplotype sharing between families affected with chromosome 1q-linked open angle glaucoma (GLC1A) were used to prioritize candidate genes for mutation screening. A gene encoding a trabecular meshwork protein (TIGR) mapped to the narrowest disease interval by STS content and radiation hybrid mapping. Thirteen glaucoma patients were found to have one of three mutations in this gene (3.9 percent of the population studied). One of these mutations was also found in a control individual (0.2 percent). Identification of these mutations will aid in early diagnosis, which is essential for optimal application of existing therapies.
- Published
- 1997
- Full Text
- View/download PDF
27. Fine mapping of the autosomal dominant juvenile open angle glaucoma (GLC1A) region and evaluation of candidate genes.
- Author
-
Sunden SL, Alward WL, Nichols BE, Rokhlina TR, Nystuen A, Stone EM, and Sheffield VC
- Subjects
- Child, Chromosome Mapping, Chromosomes, Artificial, Yeast, DNA Primers, Female, Genetic Linkage, Genetic Markers, Humans, Male, Microsatellite Repeats, Molecular Sequence Data, Pedigree, Polymerase Chain Reaction, Polymorphism, Genetic, Polymorphism, Single-Stranded Conformational, Chromosomes, Human, Pair 1, Glaucoma, Open-Angle genetics
- Abstract
Juvenile Open Angle Glaucoma (GLC1A) is an autosomal optic neuropathy that has been localized previously to chromosome 1q. Here we report the fine mapping of the disease region using YACs and a high density of polymorphic microsatellite markers. This study utilized two large JOAG pedigrees genotyped at 36 loci from chromosome 1q21-q31 to refine the GLC1A locus to a approximately 3-cM region flanked by YAC-derived microsatellite markers D1S3665 and D1S3664. The candidate genes LAMC1, NPR1, and CNR2 were excluded from the region by linkage. Four other genes, SELE, SELL, TXGP1, and APT1LG1, were determined to lie within the critical region through YAC content and linkage mapping. The YAC-STS content map of the critical region provides the groundwork for the construction of a transcription map and the identification of the disease-causing gene.
- Published
- 1996
- Full Text
- View/download PDF
28. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31.
- Author
-
Sheffield VC, Stone EM, Alward WL, Drack AV, Johnson AT, Streb LM, and Nichols BE
- Subjects
- Chromosome Mapping, Female, Genes, Dominant, Genetic Markers, Humans, Lod Score, Male, Pedigree, Polymorphism, Genetic, Receptors, Atrial Natriuretic Factor genetics, Repetitive Sequences, Nucleic Acid, Chromosomes, Human, Pair 1, Glaucoma, Open-Angle genetics
- Abstract
Glaucoma is a significant cause of blindness world wide. There is evidence to suggest that at least a subset of the disease is determined genetically. We studied 37 members of a family affected with an autosomal dominant form of juvenile open angle glaucoma and 22 were found to be affected. Linkage analysis using short tandem repeat markers mapped the disease-causing gene to chromosome 1q21-q31. Eight markers were significantly linked (Zmax > 3.0) to the disease, with the highest lod score 6.5 (theta = 0), provided by D1S212. The atrial natriuretic peptide (ANP)/receptor system has been proposed to have a role in glaucoma and one of the ANP receptor genes maps to chromosome 1q.
- Published
- 1993
- Full Text
- View/download PDF
29. Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma.
- Author
-
Johnson AT, Drack AV, Kwitek AE, Cannon RL, Stone EM, and Alward WL
- Subjects
- Adolescent, Adult, Child, Chromosome Mapping, Chromosomes, Human, Pair 4, Female, Fundus Oculi, Genetic Markers, Glaucoma, Open-Angle pathology, Humans, Intraocular Pressure, Male, Pedigree, Visual Acuity, Visual Fields, Genetic Linkage genetics, Glaucoma, Open-Angle genetics
- Abstract
Background: Juvenile glaucoma is an uncommon form of open-angle glaucoma that is usually recognized during childhood or early adulthood and which often has a strong family history., Methods: The authors clinically characterized a large multigeneration family with autosomal-dominant, juvenile-onset, open-angle glaucoma. Linkage analysis with short tandem repeat polymorphisms was used to evaluate the Rieger's syndrome locus as the site of the disease-causing mutation., Results: Forty members of a family with a five-generation history of open-angle glaucoma were examined. Clinical data were available from an additional five individuals, three of whom were decreased. Older family members provided limited information about the visual history of five other deceased individuals in the first three generations. Fifty-nine people were at 50% risk of harboring the disease-causing mutation; and of these, 30 were affected with glaucoma by examination or by family history. All affected patients had an affected parent. The average age at diagnosis was 18 years (range, 8-30 years). Affected family members tended to be myopic but lacked other ocular or systemic abnormalities. The intraocular pressures (IOPs) of affected individuals were commonly more than 50 mmHg when they were first examined. Gonioscopy showed the angles to be open, with no abnormal pigmentation, iris processes, or embryonic tissue. Topical medications were initially effective in controlling IOP, but surgery was usually required for long-term pressure control. The Rieger's syndrome locus on chromosome 4q25 was excluded as the site of the disease-causing mutation., Conclusion: Juvenile open-angle glaucoma can occur as an autosomal dominant trait with high penetrance. Genetic linkage analysis of the family reported here has the potential to identify the chromosomal location of a glaucoma-causing gene. This gene is genetically distinct from the chromosome 4 locus that was recently associated with Rieger's syndrome.
- Published
- 1993
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.